Tenaya Therapeutics, Inc.
TNYA
$0.4111
-$0.0028-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.10% | -11.91% | -4.65% | 0.62% | 4.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.39% | -11.62% | -8.60% | -5.74% | 2.37% |
| Operating Income | 16.39% | 11.62% | 8.60% | 5.74% | -2.37% |
| Income Before Tax | 15.10% | 10.44% | 8.18% | 6.56% | -0.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.10% | 10.44% | 8.18% | 6.56% | -0.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.10% | 10.44% | 8.18% | 6.56% | -0.18% |
| EBIT | 16.39% | 11.62% | 8.60% | 5.74% | -2.37% |
| EBITDA | 17.77% | 12.27% | 9.14% | 6.21% | -1.63% |
| EPS Basic | 29.60% | 22.00% | 23.59% | 31.15% | 33.23% |
| Normalized Basic EPS | 29.61% | 22.02% | 23.60% | 31.16% | 33.24% |
| EPS Diluted | 29.45% | 21.85% | 23.45% | 31.15% | 33.30% |
| Normalized Diluted EPS | 29.61% | 22.02% | 23.60% | 31.16% | 33.24% |
| Average Basic Shares Outstanding | 21.74% | 15.19% | 18.60% | 29.45% | 43.31% |
| Average Diluted Shares Outstanding | 21.74% | 15.19% | 18.60% | 29.45% | 43.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |